• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 2 days ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 4 months 4 weeks ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 4 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

TEMPOtest-QC

portrait of John P. Hays

Dr John P. Hays

Scientific Coordinator of TEMPOtest-QC, based at Erasmus University Medical Centre in Rotterdam, the Netherlands

Research field

Microbiology, Diagnostics, Bacteriology

If you like this
If you want to know more
Research Profile

Who?

Microbiologist Dr John P. Hays is concerned about the increasing resistance of bacteria to antibiotics. Dr Hays: “The problem is very acute: in two decades, society may return to the pre-antibiotic era”. Dr Hays and his team fight this major health problem by evaluating and validating rapid tests to identify bacteria.

Why?

The introduction of antibiotics has saved many millions of lives since their discovery in 1928. However, bacteria are becoming increasingly resistant to these antibiotics. The aim of TEMPOtest-QC is to limit antibiotic resistance by improving diagnosis. This is of vital importance to public health.

What?

The development of antibiotic resistance can be limited by an effective therapy that is based on accurate diagnosis. Medical doctors need to be able to rapidly identify disease-causing bacteria in order to correctly prescribe antibiotics. To this end, TEMPOtest-QC aims to evaluate and validate novel rapid tests.

How?

The EU grant enables TEMPOtest-QC scientists to share their expertise and skills. Dr Hays: “We create collections of bacterial isolates and evaluate new technologies. We also collect the views of the general public and medical professionals about obstacles and benefits to the implementation of rapid diagnostic tests”.

Join the fight against resistant bacteria

In the Picture
In the Picture
TEMPOtest-QC project website In Focus article 'Looking for new antibiotics' PDF versionPDF version
Image credits

Background image: TEMPOtest-QC

Portrait of the project coordinator: TEMPOtest-QC

Timeline (in chronological order): TEMPOtest-QC